Based on the Celadon Pharmaceuticals PLC stock forecast from 0 analysts, the average analyst target price for Celadon Pharmaceuticals PLC is not available over the next 12 months. Celadon Pharmaceuticals PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Celadon Pharmaceuticals PLC is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Celadon Pharmaceuticals PLC’s stock price was GBX 29.50. Celadon Pharmaceuticals PLC’s stock price has changed by +7.27% over the past week, -16.90% over the past month and -69.74% over the last year.
No recent analyst target price found for Celadon Pharmaceuticals PLC
No recent average analyst rating found for Celadon Pharmaceuticals PLC
Company Overview Celadon Pharmaceuticals PLC
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom. Read Less
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spe...Read More
Frequently Asked Questions About Celadon Pharmaceuticals PLC (CEL:LSE) Stock
Stock Target Advisor's fundamental analysis for Celadon Pharmaceuticals PLC's stock is Bearish.
Unfortunately we do not have enough data on CEL:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CEL:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on CEL:LSE's stock to indicate if its overvalued.
The last closing price of CEL:LSE's stock was GBX 29.50.
The most recent market capitalization for CEL:LSE is GBX 0.02B.
Unfortunately we do not have enough analyst data on CEL:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Celadon Pharmaceuticals PLC's stock.
As per our most recent records Celadon Pharmaceuticals PLC has 27 Employees.
Celadon Pharmaceuticals PLC's registered address is 32-33 Cowcross Street, London, United Kingdom, EC1M 6DF.
You can get more information about it from Celadon Pharmaceuticals PLC's website at https://celadonpharma.com/.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Celadon Pharmaceuticals PLC (CEL:LSE) Stock
Stock Target Advisor's fundamental analysis for Celadon Pharmaceuticals PLC's stock is Bearish.
Unfortunately we do not have enough data on CEL:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CEL:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on CEL:LSE's stock to indicate if its overvalued.
The last closing price of CEL:LSE's stock was GBX 29.50.
The most recent market capitalization for CEL:LSE is GBX 0.02B.
Unfortunately we do not have enough analyst data on CEL:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Celadon Pharmaceuticals PLC's stock.
As per our most recent records Celadon Pharmaceuticals PLC has 27 Employees.
Celadon Pharmaceuticals PLC's registered address is 32-33 Cowcross Street, London, United Kingdom, EC1M 6DF.
You can get more information about it from Celadon Pharmaceuticals PLC's website at https://celadonpharma.com/.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CEL:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
